Molina V - Search Results

1

Cerebral metabolism and risperidone treatment in schizophrenia.

Molina V, Gispert JD, Reig S, Sanz J, Pascau J, Santos A, Palomo T, Desco M. Molina V, et al. Schizophr Res. 2003 Mar 1;60(1):1-7. doi: 10.1016/s0920-9964(02)00199-8. Schizophr Res. 2003. PMID: 12505132

2

P300 amplitude as a possible correlate of frontal degeneration in schizophrenia.

Martín-Loeches M, Molina V, Muñoz F, Hinojosa JA, Reig S, Desco M, Benito C, Sanz J, Gabiri A, Sarramea F, Santos A, Palomo T. Martín-Loeches M, et al. Among authors: molina v. Schizophr Res. 2001 Apr 15;49(1-2):121-8. doi: 10.1016/s0920-9964(00)00125-0. Schizophr Res. 2001. PMID: 11343871

3

Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia.

Molina V, Reig S, Sanz J, Benito C, Pascau J, Collazos F, Sarramea F, Artaloytia JF, Gispert JD, Luque R, Palomo T, Arango C, Desco M. Molina V, et al. Schizophr Res. 2002 Dec 1;58(2-3):305-12. doi: 10.1016/s0920-9964(02)00166-4. Schizophr Res. 2002. PMID: 12409171

4

Cerebral metabolic patterns in chronic and recent-onset schizophrenia.

Desco M, Gispert JD, Reig S, Sanz J, Pascau J, Sarramea F, Benito C, Santos A, Palomo T, Molina V. Desco M, et al. Among authors: molina v. Psychiatry Res. 2003 Feb 15;122(2):125-35. doi: 10.1016/s0925-4927(02)00124-5. Psychiatry Res. 2003. PMID: 12714176

5

Multimodal neuroimaging studies and neurodevelopment and neurodegeneration hypotheses of schizophrenia.

Molina V, Reig S, Desco M, Gispert JD, Sanz J, Sarramea F, Pascau J, Benito C, Martínez-Lázaro R, Luque R, Aragües M, Misiego JM, Corral IL, Palomo T. Molina V, et al. Neurotox Res. 2002 Aug-Sep;4(5-6):437-451. doi: 10.1080/10298420290031397. Neurotox Res. 2002. PMID: 12754158

6

Influence of the normalization template on the outcome of statistical parametric mapping of PET scans.

Gispert JD, Pascau J, Reig S, Martínez-Lázaro R, Molina V, García-Barreno P, Desco M. Gispert JD, et al. Among authors: molina v. Neuroimage. 2003 Jul;19(3):601-12. doi: 10.1016/s1053-8119(03)00072-7. Neuroimage. 2003. PMID: 12880791 Clinical Trial.

7

Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia.

Molina V, Reig S, Sarramea F, Sanz J, Francisco Artaloytia J, Luque R, Aragüés M, Pascau J, Benito C, Palomo T, Desco M. Molina V, et al. Psychiatry Res. 2003 Nov 30;124(3):153-61. doi: 10.1016/s0925-4927(03)00108-2. Psychiatry Res. 2003. PMID: 14623067

8

Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia.

Molina V, Reig S, Pascau J, Sanz J, Sarramea F, Gispert JD, Luque R, Benito C, Palomo T, Desco M. Molina V, et al. Psychiatry Res. 2003 Nov 30;124(3):163-75. doi: 10.1016/s0925-4927(03)00107-0. Psychiatry Res. 2003. PMID: 14623068

9

Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia.

Molina V, Sanz J, Benito C, Palomo T. Molina V, et al. Int Clin Psychopharmacol. 2004 Jul;19(4):221-8. doi: 10.1097/01.yic.0000125753.01426.d7. Int Clin Psychopharmacol. 2004. PMID: 15201569

10

Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients.

Molina V, Sanz J, Sarramea F, Benito C, Palomo T. Molina V, et al. Psychiatry Res. 2004 May 30;131(1):45-56. doi: 10.1016/j.pscychresns.2004.01.005. Psychiatry Res. 2004. PMID: 15246454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters